Anticancer Drugs in Immunotherapy: Molecular Mechanisms, Translational Insights, and Clinical Applications

A special issue of Biomedicines (ISSN 2227-9059). This special issue belongs to the section "Cancer Biology and Oncology".

Deadline for manuscript submissions: 28 February 2026 | Viewed by 14

Special Issue Editor


E-Mail Website
Guest Editor
Department of Pathology, UPMC Hillman Cancer Center, University of Pittsburgh, Pittsburgh, PA, USA
Interests: cancer genetics and immunobiology; cancer biology and drug discovery; immunotherapy resistance
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

The advent of immune checkpoint inhibitors, adoptive cell therapies, and immune adjuvants has revolutionized cancer therapy. However, the efficacy of immunotherapy is limited by resistance, immune evasion, and tumor microenvironmental barriers. Anticancer drugs, including chemotherapeutics, targeted agents, and novel small molecules, are now being integrated into immunotherapy regimens to enhance antitumor immunity and overcome resistance.

This Special Issue aims to explore the synergistic mechanisms by which anticancer drugs modulate the immune landscape, influence immunogenic cell death, or augment checkpoint blockade. We welcome studies that dissect molecular pathways, investigate drug–immune cell interactions, propose biomarkers for response, and highlight the clinical translation of drug–immunotherapy combinations.

Topics of interest include (but are not limited to) the following:

  • Mechanisms of immunogenic cell death induced by chemotherapy or radiation;
  • Small molecules and targeted drugs enhancing T-cell priming or APC function;
  • Drug-induced modulation of tumor immune microenvironment;
  • Epigenetic drugs and immune reprogramming;
  • Overcoming resistance to checkpoint blockade with drug combinations;
  • Immunotherapy sensitization in “cold” tumors via conventional agents;
  • Clinical trials involving anticancer drugs combined with immunotherapy;
  • Nanoparticle and drug-delivery systems for immune activation;
  • Bioinformatics and systems biology approaches to predict synergy.

Dr. Bashir Lawal
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomedicines is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • immunotherapy
  • immune checkpoint inhibitors
  • drug synergy
  • immunogenic cell death
  • tumor microenvironment
  • cancer immunology
  • combination therapy
  • chemotherapy
  • targeted therapy
  • translational oncology

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.

Further information on MDPI's Special Issue policies can be found here.

Published Papers

This special issue is now open for submission.
Back to TopTop